Abstract The tumor suppressor gene TP53 produces multiple p53 protein isoforms through alternative promoter usage, messenger RNA splicing, and alternative translation initiation. These isoforms can differentially shape canonical p53 outputs, including cell-cycle arrest, senescence, apoptosis, and DNA-damage responses, and are increasingly recognized as context-dependent regulators of tumor progression and treatment response.